Intimate Men’s Health Workshop in Copenhagen – February 2024

Focus of the Instruction

The training focused on men’s health indications, the initial consultation, treatment plans, ESWT, EMTT, and diagnostic ultrasound. The key point here was to link measurements and imaging to clinical decision-making, so that the technology does not become an end in itself. When I teach, my goal is for participants to be able to explain why a particular treatment is chosen, who it is suitable for, and when a different approach is more appropriate.

Why this is relevant to a patient’s journey

Ultrasound is particularly relevant when symptoms and treatment choices depend on anatomy or blood flow. It can provide a more detailed view of tissues, vessels, plaque, or other structural conditions, thereby reducing the risk of treatment being chosen based solely on symptoms. EMTT and other electromagnetic technologies should be considered as supplements, not as substitutes for diagnostic testing. The clinical value lies in understanding which tissues and mechanisms one is attempting to influence, and how the technology can be combined with other interventions without making the treatment plan unnecessarily complex.

The same sequence applies in my clinical work at MS Insight. The symptom is the starting point, not the diagnosis. Only once the likely mechanisms have been narrowed down does it make sense to discuss the device, dosage, number of treatments, and combinations.

From Education to Clinical Quality

For me, teaching is part of maintaining my professional skills. I need to be able to explain the technology accurately, defend my clinical decisions, and at the same time be clear about the limitations of the evidence. This process is relevant to patients because it refines patient selection, helps manage expectations, and enhances the ability to opt out of treatment when the indication isn’t strong enough.

Another important element is managing expectations. In areas such as sexual function, chronic pain, and incontinence, two patients with the same diagnosis may have vastly different causes and prognoses. Therefore, it is important to be precise about which problem is being addressed, how progress is measured, and when a lack of response should lead to a reassessment rather than simply continuing with the same treatment.

I also emphasize the importance of distinguishing between mechanism, clinical evidence, and marketing. The fact that a technology can biologically affect tissue does not mean that it has a documented effect on all indications. Conversely, clinical evidence may be relevant without being directly transferable between different devices, doses, or patient groups. This distinction is crucial both in teaching and in conversations with patients.

It is the professional connection between education and clinical practice that I want these educational activities to demonstrate: not a promise of results, but experience in critically evaluating technology, following the evidence, and translating it into more precise decisions for each individual patient.

Read more: Diagnosis and treatment of erectile dysfunction · Men’s Health workshops for healthcare professionals · Ultrasound imaging in clinical assessment

Documentation: This article is based on publicly available event materials and/or LinkedIn posts. Sources: LinkedIn posts